Literature DB >> 19302854

Hyperbaric oxygen therapy reduces the severity of necrotizing enterocolitis in a neonatal rat model.

Ahmet Guven1, Gokhan Gundogdu, Bulent Uysal, Hakan Cermik, Mustafa Kul, Suzi Demirbag, Haluk Ozturk, Sukru Oter.   

Abstract

INTRODUCTION: Hyperbaric oxygen (HBO) therapy is known to increase oxygen concentration in tissues leading to induction of an adaptive increase in antioxidants, stimulation of angiogenesis, improvement of white blood cell action, and regulation of inflammatory process. Therefore, we tested the potential beneficial effect of HBO in neonatal rat model of necrotizing enterocolitis (NEC).
MATERIALS AND METHODS: Thirty newborn Sprague-Dawley rats, provided by the Experimental Research Council, Gulhane Military Medical Academy, Ankara,Turkey, were randomly divided into 3 groups as follows: NEC, NEC + HBO, and control. Necrotizing enterocolitis was induced by enteral formula feeding and exposure to hypoxia after cold stress at 4 degrees C and oxygen. The NEC + HBO group received HBO at 2.8 atmosphere absolute (ATA) for 90 minutes daily for 3 days. The pups were killed on the fourth day, and their intestinal tissues were harvested for biochemical and histopathologic analysis. Blood samples were also obtained from the pups.
RESULTS: The mortality rate was highest in the NEC group (3 pups in the NEC group vs 1 pup in the NEC + HBO group). Malondialdehyde and protein carbonyl content were significantly increased, whereas superoxide dismutase and glutathione peroxidase were significantly decreased in the NEC group. All these changes were similar to control levels in the NEC group by HBO treatment. Nitrate plus nitrite (NO(x)) levels and serum tumor necrosis factor alpha were increased in the NEC group and histopathologic injury score and apoptosis index in the NEC group were significantly higher than in the NEC + HBO group.
CONCLUSION: Hyperbaric oxygen significantly reduced the severity of NEC in our study.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19302854     DOI: 10.1016/j.jpedsurg.2008.06.008

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  8 in total

1.  Beneficial effects of Etanercept on experimental necrotizing enterocolitis.

Authors:  Sadık Yurttutan; Ramazan Ozdemir; Fuat Emre Canpolat; Mehmet Yekta Oncel; Hatice Germen Unverdi; Bülent Uysal; Ömer Erdeve; Ugur Dilmen
Journal:  Pediatr Surg Int       Date:  2013-09-27       Impact factor: 1.827

2.  A spectrum of intestinal injury models in neonatal mice.

Authors:  Augusto Zani; Elke Zani-Ruttenstock; Forouhideh Peyvandi; Carol Lee; Bo Li; Agostino Pierro
Journal:  Pediatr Surg Int       Date:  2015-11-09       Impact factor: 1.827

3.  Hyperbaric oxygen treatment for inflammatory bowel disease: a systematic review and analysis.

Authors:  Daniel A Rossignol
Journal:  Med Gas Res       Date:  2012-03-15

Review 4.  Oxidative Stress Related Diseases in Newborns.

Authors:  Yasemin Ozsurekci; Kubra Aykac
Journal:  Oxid Med Cell Longev       Date:  2016-06-15       Impact factor: 6.543

5.  Effects of hypothermia on skeletal ischemia reperfusion injury in rats.

Authors:  Şafak Ekinci; Ümit Kaldırım; Faruk Akyıldız; Serkan Bilgiç; Kenan Koca; Yavuz Poyrazoğlu; Ozgür Selim Uysal; Hasan Turğut; Selim Türkkan; Ömer Erşen; Turgut Topal; Huseyin Ozkan
Journal:  Open Med (Wars)       Date:  2015-02-27

6.  What really causes necrotising enterocolitis?

Authors:  Thomas Peter Fox; Charles Godavitarne
Journal:  ISRN Gastroenterol       Date:  2012-12-17

7.  Hyperbaric oxygen therapy stimulates colonic stem cells and induces mucosal healing in patients with refractory ulcerative colitis: a prospective case series.

Authors:  Mohamed Bekheit; Nahed Baddour; Khaled Katri; Yousry Taher; Khaled El Tobgy; Essam Mousa
Journal:  BMJ Open Gastroenterol       Date:  2016-04-28

8.  Hyperbaric Oxygen Increases Stem Cell Proliferation, Angiogenesis and Wound-Healing Ability of WJ-MSCs in Diabetic Mice.

Authors:  Isaac Peña-Villalobos; Ignacio Casanova-Maldonado; Pablo Lois; Catalina Prieto; Carolina Pizarro; José Lattus; Germán Osorio; Verónica Palma
Journal:  Front Physiol       Date:  2018-07-30       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.